MedPath

Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Registration Number
NCT01331629
Lead Sponsor
Centre Francois Baclesse
Brief Summary

The purpose of this study is to compare intervention by Art-therapy to standard care in patients treated with adjuvant radiotherapy for breast cancer and evaluate the fatigue.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
322
Inclusion Criteria
  • Breast cancer surgery (invasive or in situ) by conservative surgery
  • Age ≥ 18 years
  • Indication of adjuvant radiotherapy
  • Adjuvant chemotherapy allowed
  • Agreeing to participate in a clinical study
  • Able to participate in a clinical trial
Exclusion Criteria
  • Metastatic Breast Cancer
  • Personal history of breast cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
evaluate persistent fatigueup to 12 months after radiotherapy

Estimate the decrease in the proportion of patients with persistent fatigue after one month of radiotherapy in patients receiving an approach from art therapy as a complement to standard care compared to those with care standard alone.

Evaluated by auto-questionnary

Secondary Outcome Measures
NameTimeMethod
Evaluate the quality of life patients.up to 12 months after radiotherapy

Evaluate the quality of life patients (by auto-questionnary)

Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives Assess the impact of the condition of patients on the reactions, depression and anxiety of relativesup to 12 months after radiotherapy

Assess the impact of the condition of patients on the reactions, depression and anxiety of relatives (by auto-questionnary)

Evaluate the fatigue away from the treatment (at 6 months and 1 year) of patients6 months and 12 months after treatment

Evaluate the fatigue away from the treatment (at 6 months and 1 year) of patients (by auto-questionnary)

Evaluate the anxiety of patientsup 12 months after radiotherapy

Evaluate the anxiety of patients (by auto-questionnary)

evaluate the depression of patientsup 12 months after study

evaluate the depression of patients (by auto-questionnary)

Evaluate the quality of life away from the treatment (at 6 months and 1 year) of patients6 months and 1 year after treatment

Evaluate the quality of life away from the treatment (at 6 months and 1 year) of patients (by auto-questionnary)

Trial Locations

Locations (6)

Centre François BACLESSE

🇫🇷

Caen, Calvados, France

CHU

🇫🇷

Grenoble, Isère, France

Centre Oscar LAMBRET

🇫🇷

Lille, Nord, France

Centre Henri Becquerel

🇫🇷

Rouen, Seine Maritime, France

Centre Antoine LACASSAGNE

🇫🇷

Nice, France

Institut Jean Godinot

🇫🇷

Reims, France

Centre François BACLESSE
🇫🇷Caen, Calvados, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.